Genome-wide association studies in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Human Molecular Genetics

• Publication date

  2009-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddp406PMID 19808789PMCID PMC2758713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Oncogene].

  2019cited by this paper
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

  2009cited by this paper
• Validating, augmenting and refining genome-wide association signals

  2009cited by this paper
• Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.

  2009cited by this paper
• S5‐03‐06: Homozygous APP mutations and Alzheimer's disease

  2009cited by this paper
• S5‐01‐01: Molecular neuropathology of frontotemporal lobar degeneration

  2009cited by this paper
• Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease

  2009cited by this paper
• Genome screen of late‐onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results.

  2009cited by this paper
• Genome-wide association studies for complex traits: consensus, uncertainty and challenges

  2008cited by this paper
• Galanin Hyperinnervation Upregulates Choline Acetyltransferase Expression in Cholinergic Basal Forebrain Neurons in Alzheimer’s Disease

  2008cited by this paper
• Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.

  2008cited by this paper
• Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.

  2008cited by this paper
• A genome-wide association study for late-onset Alzheimer's disease using DNA pooling

  2008cited by this paper
• Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses

  2008cited by this paper
• Assessment of cumulative evidence on genetic associations: interim guidelines.

  2008cited by this paper
• A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.

  2007cited by this paper
• Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants.

  2007cited by this paper
• Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

  2007cited by this paper
• GAB2 Alleles Modify Alzheimer's Risk in APOE ε4 Carriers

  2007cited by this paper
• Genomewide weighted hypothesis testing in family-based association studies, with an application to a 100K scan.

  2007cited by this paper
• Amyloid Precursor Protein and Presenilin1 Interact with the Adaptor GRB2 and Modulate ERK 1,2 Signaling*

  2007cited by this paper
• Thirty-eight-negative kinase 1 (TNK1) facilitates TNFalpha-induced apoptosis by blocking NF-kappaB activation.

  2007cited by this paper
• GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.

  2007cited by this paper
• Thirty-eight-negative kinase 1 (TNK1) facilitates TNFα-induced apoptosis by blocking NF-κB activation

  2007cited by this paper
• Evaluating coverage of genome-wide association studies

  2006cited by this paper
• TRUSS, a tumor necrosis factor receptor‐1‐interacting protein, activates c‐Jun NH2‐terminal kinase and transcription factor AP‐1

  2006cited by this paper
• ReviewTwenty Years of the Alzheimer ’ s Disease Amyloid Hypothesis : A Genetic Perspective

  2005cited by this paper
• Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

  2005cited by this paper
• Presenilin-dependent Processing and Nuclear Function of γ-Protocadherins*

  2005cited by this paper
• Presenilin-dependent processing and nuclear function of gamma-protocadherins.

  2005cited by this paper
• Molecular diagnosis of autosomal dominant early onset Alzheimer’s disease: an update

  2005cited by this paper
• Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

  2004cited by this paper
• Clearance of Alzheimer's Aβ Peptide

  2004cited by this paper
• Early onset familial Alzheimer’s disease

  2002cited by this paper
• Cloning and characterization of a novel Krüppel-like zinc finger gene, ZNF268, expressed in early human embryo.

  2001cited by this paper
• Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease

  2001cited by this paper
• Rhamnogalacturonan acetylesterase elucidates the structure and function of a new family of hydrolases.

  2000cited by this paper
• Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain

  2000cited by this paper
• Research in Health Care

  1996cited by this paper
• Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

  1996cited by this paper
• Polymorphisms in the human apolipoprotein-J/clusterin gene: ethnic variation and distribution in Alzheimer’s disease

  1996cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Expression cloning of a novel zinc finger protein that binds to the c-fos serum response element

  1992cited by this paper

• Shared Genetic Basis and Causality Between Epilepsy and Psychiatric Disorders: Evidence From a Comprehensive Genetic Analysis

  2026cites this paper
• Characterizing Dementia Phenotypes from Unstructured EHR Notes with Generative AI and Interpretable Machine Learning

  2025cites this paper
• A central role for acetylcholine in entorhinal cortex function and dysfunction with age in humans and mice.

  2025cites this paper
• Associations Between Diabetes Mellitus and Neurodegenerative Diseases

  2025cites this paper
• Explainable AI predicting Alzheimer's disease with latent multimodal deep neural networks.

  2025cites this paper
• Optimizing Alzheimer's diagnosis and precision medicine: A narrative review unlocking the potential of multiomics markers

  2025cites this paper
• Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells

  2025cites this paper
• Human Glucose Transporters in Health and Selected Neurodegenerative Diseases

  2025cites this paper
• iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype

  2024cites this paper
• Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease

  2024cites this paper
• Perspectivas innovadoras sobre el valor de las pruebas diagnósticas en la práctica clínica

  2024cites this paper
• Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications

  2024cites this paper
• Decoding molecular mechanisms: brain aging and Alzheimer’s disease

  2024cites this paper
• Role of 14-3-3 protein family in the pathobiology of EBV in immortalized B cells and Alzheimer’s disease

  2024cites this paper
• iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta

  2024cites this paper
• Leveraging electronic health records and knowledge networks for Alzheimer’s disease prediction and sex-specific biological insights

  2024cites this paper
• Deep learning analysis of fMRI data for predicting Alzheimer’s Disease: A focus on convolutional neural networks and model interpretability

  2024cites this paper
• Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease

  2024cites this paper
• Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research

  2024cites this paper
• Loss of cholinergic input to the entorhinal cortex is an early indicator of cognitive impairment in natural aging of humans and mice

  2024cites this paper
• Machine Learning Approach to Identify Case-Control Studies on ApoE Gene Mutations Linked to Alzheimer’s Disease in Italy

  2024cites this paper
• Proteomic Profiling Reveals Age-Related Changes in Transporter Proteins in the Human Blood-Brain Barrier

  2024cites this paper
• Alzheimer’s risk variant in CLU is associated with neural inefficiency in healthy individuals

  2023cites this paper
• The amyloid cascade hypothesis: an updated critical review.

  2023cites this paper
• Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease

  2023cites this paper
• The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes

  2023cites this paper
• Leveraging Electronic Medical Records and Knowledge Networks to Predict Disease Onset and Gain Biological Insight Into Alzheimer's Disease

  2023cites this paper
• A multi-network approach to Alzheimer’s Disease gene prioritization complements cis-regulatory prioritization with molecular quantitative trait loci

  2023cites this paper
• SCING: Inference of robust, interpretable gene regulatory networks from single cell and spatial transcriptomics

  2023cites this paper
• Mistranslation-associated perturbations of proteostasis do not promote accumulation of amyloid beta and plaque deposition in aged mouse brain

  2023cites this paper
• Obesity and Alzheimer’s: An attempt to decipher the role of obesity in blood–brain barrier degradation

  2023cites this paper
• Receptor Recycling by Retromer

  2023cites this paper
• A simulative deep learning model of SNP interactions on chromosome 19 for predicting Alzheimer's disease risk and rates of disease progression

  2023cites this paper
• Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer’s disease

  2023cites this paper
• X chromosome-wide association study of quantitative biomarkers from the Alzheimer’s Disease Neuroimaging Initiative study

  2023cites this paper
• All roads lead to heterogeneity: The complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer’s disease

  2022cites this paper
• Genome-Wide Association Study of Potential Meat Quality Trait Loci in Ducks

  2022cites this paper
• Commentary: BAG3 as a mediator of endosome function and tau clearance.

  2022cites this paper
• Editorial: Multi-omics, Epigenomics, and Computational Analysis of Neurodegenerative Disorders

  2022cites this paper
• APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge

  2022cites this paper
• Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease: Review and Meta-Analysis

  2022cites this paper
• INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease

  2022cites this paper
• Exploring and Exploiting a Common Pathophysiology of Type 2 Diabetes and Alzheimer’s Disease

  2022cites this paper
• The noncatalytic regions of the tyrosine kinase Tnk1 are important for activity and substrate specificity

  2022cites this paper
• M1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease

  2022cites this paper
• Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders

  2022cites this paper
• inMTSCCA: An Integrated Multi-task Sparse Canonical Correlation Analysis for Multi-omic Brain Imaging Genetics

  2022cites this paper
• iPSC-Derived PSEN2 (N141I) Astrocytes and Microglia Exhibit a Primed Inflammatory Phenotype

  2022cites this paper
• Influence of Genetic and Cardiometabolic Risk Factors in Alzheimer's Disease.

  2022influential citation
• Retromer dysfunction at the nexus of tauopathies

  2021cites this paper
• “Omics” in traumatic brain injury: novel approaches to a complex disease

  2021cites this paper
• Alzheimer's Disease: Pathogenesis and Therapeutic interventions.

  2021cites this paper
• Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment

  2021cites this paper
• Activation of M1 muscarinic receptors reduce pathology and slow progression of neurodegenerative disease

  2021cites this paper
• Plasma Sphingomyelins in Late-Onset Alzheimer’s Disease

  2021cites this paper
• APOE2 mitigates disease-related phenotypes in an isogenic hiPSC-based model of Alzheimer’s disease

  2021cites this paper
• Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice?

  2021cites this paper
• A Comparison of the Knowledge of Alzheimer’s Disease among Community Pharmacists Based on Regional Practice Setting Using the Alzheimer’s Disease Knowledge Scale (ADKS)

  2021cites this paper
• Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer’s disease

  2021cites this paper
• The cellular machinery of post-endocytic APP trafficking in Alzheimer's disease: A future target for therapeutic intervention?

  2020cites this paper
• Building research in diet and cognition (BRIDGE): Baseline characteristics of older obese African American adults in a randomized controlled trial to examine the effect of the Mediterranean diet with and without weight loss on cognitive functioning

  2020cites this paper
• Neurogenetic and Neuroepigenetic Mechanisms in Cognitive Health and Disease

  2020cites this paper
• Polymorphism rs11867353 of Tyrosine Kinase Non-Receptor 1 (TNK1) Gene Is a Novel Genetic Marker for Alzheimer’s Disease

  2020cites this paper
• A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy

  2020cites this paper
• The Other Side of Alzheimer’s Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers

  2020cites this paper
• APOE and metabolic dysfunction in Alzheimer's disease.

  2020cites this paper
• Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia

  2020cites this paper
• Investigation of Genome-Wide Association SNPs and Alzheimer’s Disease

  2020cites this paper
• Generating Cell Type-Specific Protein Signatures from Non-symptomatic and Diseased Tissues

  2020cites this paper
• The Genetics of Alzheimer’s Disease in the Chinese Population

  2020cites this paper
• Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer’s Disease in a Prospective Cohort Study

  2020cites this paper
• Green Tea Seed Isolated Theasaponin E1 Ameliorates AD Promoting Neurotoxic Pathogenesis by Attenuating Aβ Peptide Levels in SweAPP N2a Cells

  2020cites this paper
• Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies

  2019cites this paper
• Modern approaches to investigating non‐neuronal aspects of Alzheimer's disease

  2019cites this paper
• New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases

  2019cites this paper
• A Microglial Signature Directing Human Aging and Neurodegeneration-Related Gene Networks

  2019cites this paper
• Application of anti-amyloid beta immunization using encapsulated cell technology in mouse models of Alzheimer's disease

  2019cites this paper
• Assessing the therapeutic potential of Graptopetalum paraguayense on Alzheimer’s disease using patient iPSC-derived neurons

  2019cites this paper
• Modeling Neurological Disorders with Human Pluripotent Stem Cell-Derived Astrocytes

  2019cites this paper
• Demographic characterization of a dementia outpatient clinic in a tertiary referral hospital and study of prognostic factors for the progression of mild cognitive impairment to dementia

  2019cites this paper
• Human leukocyte antigen in sickness and in health : Ankylosing spondylitis and HLA in Sweden

  2019cites this paper
• Gene Therapy

  2019cites this paper
• A Systems Perspective of Complex Diseases: From Reductionism to Integration

  2018cites this paper
• Success and failure in replication of genotype–phenotype associations: How does replication help in understanding the genetic basis of phenotypic variation in outbred populations?

  2018cites this paper
• Polygenic Risk Score for Alzheimer's Disease: Implications for Memory Performance and Hippocampal Volumes in Early Life.

  2018cites this paper
• Informative combination of CLU rs11136000, serum HDL levels, diabetes, and age as a new piece of puzzle-picture of predictive medicine for cognitive disorders

  2018cites this paper
• Detecting potential pleiotropy across cardiovascular and neurological diseases using univariate, bivariate, and multivariate methods on 43,870 individuals from the eMERGE network

  2018cites this paper
• Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer’s Disease Cerebrospinal Fluid Biomarkers

  2018cites this paper
• Apolipoproteins and Alzheimer's pathophysiology

  2018cites this paper
• Cortical astroglia undergo transcriptomic dysregulation in the G93A SOD1 ALS mouse model

  2018cites this paper
• Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits

  2018cites this paper
• Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease

  2018cites this paper
• Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review

  2018influential citation
• Aging, cognitive decline, apolipoprotein E and docosahexaenoic acid metabolism

  2018cites this paper
• Dementia and the Health of the Nation

  2018cites this paper
• Transgenic Mice are not Valid for Late Onset Alzheimer’s Disease

  2018cites this paper
• Neurology in the Light of Genomics: Application of NGS and GWAS in Understanding Complex Neurological Disorders

  2018cites this paper
• Alzheimer’s disease: How metal ions define β-amyloid function

  2017cites this paper
• Effect of age and the APOE gene on metabolite concentrations in the posterior cingulate cortex

  2017cites this paper
• VariFunNet, an integrated multiscale modeling framework to study the effects of rare non-coding variants in genome-wide association studies: Applied to Alzheimer's disease

  2017influential citation